Epsilon Healthcare (ASX:EPN) said its unit, Epsilon Pharma, has been granted a renewal of its medicinal cannabis permit, according to a Tuesday Australian bourse filing.
The unit is now allowed to manufacture more quantities compared to previous permits, reflecting increased activities for the upcoming twelve months, the filing added.
The unit now also possesses an export licence and an import permit, per the filing.